Home /
About Us /
News and Publications /
Press Center /
CTCA at Eastern Regional Medical Center Fact Sheet
CTCA at Eastern Regional Medical Center Fact Sheet
Overview
- The Philadelphia hospital (Eastern Regional Medical Center) is part of CTCA’s national network of cancer hospitals and community treatment centers in Zion, Illinois; Tulsa, Oklahoma; Philadelphia, Pennsylvania and Seattle, Washington.
- CTCA provides comprehensive cancer care by integrating leading-edge medical treatments with naturopathic medicine, nutrition, oncology rehabilitation, psychological counseling, spiritual support and pain management.
- Specializes in late stage cancer, treating all major adult forms of the disease.
- CTCA has served cancer patients throughout the central United States for nearly 20 years.
- The Philadelphia hospital opened its doors on December 19, 2005 and was the first CTCA hospital on the east coast.
- Philadelphia address: Cancer Treatment Centers of America, 1331 E. Wyoming Ave., Philadelphia, PA 19124.
- Eastern is currently 130,000 square feet and three stories tall with the ability to build out 60,000 square feet in the future.
- Before the Philadelphia hospital opened, 20% of CTCA’s current patients flew from the east coast to other CTCA hospitals for CTCA’s unique cancer treatment.
- The Philadelphia hospital has a capacity of 18 inpatient rooms, 4 ICU, 2 surgical suites, 18 outpatient guest rooms and 16 infusion suites.
- This year the Philadelphia hospital employs approximately 170 people and will staff approximately 500 medical and administrative staff within the next three years.
- The Philadelphia hospital offers some of the most advanced diagnostic and therapeutic technology in cancer treatment – including Temporary High Dose Rate Brachytherapy, Mammography, IMRT and TomoTherapy®.
- The Philadelphia hospital is the first in the Delaware Valley to bring TomoTherapy® to the region. TomoTherapy® HI-ART Systema is the first device to provide 3-D imaging immediately prior to each treatment to verify the location of a patient’s tumor. In addition, the system’s ability to deliver treatment from any angle enables radiation treatment to be dispensed accurately and precisely to the tumor itself, minimizing damage to healthy cells.
- Headquartered in Schaumburg, Illinois, CTCA is a privately held network of cancer treatment hospitals and outpatient oncology clinics.
Programs and Services
- Medical Oncology
- Radiation Therapy
- Surgical Oncology
- Plastic & Reconstructive Surgery
- Nutrition
- Naturopathic Medicine
- Mind-Body Medicine
- Spiritual Support
- Oncology Rehabilitation
- Pain Management
History of CTCA at Eastern Regional Medical Center
- Cancer Treatment Centers of America was founded in 1988 by Richard J Stephenson in honor of his mother, who lost her battle with cancer in 1982. He was challenged to create a better experience for cancer patients that empowers them to participate in their treatment.
- Today, CTCA provides a comprehensive, multidisciplinary path to cancer care by integrating leading-edge medical treatments with naturopathic medicine, nutrition, oncology rehabilitation, psychological counseling, spiritual support and pain management.
Hospital’s Trademark Principles
- Whole Person and Integrative Care where oncologists work closely with staff nutritionists, mind-body therapists, naturopathic doctors, physical therapists and spiritual support to treat the whole person all under one roof.
- Mother Standard®, a standard required at CTCA that exceeds the level found at most hospitals. This is the standard of care CTCA staff would want for their own mothers. The Mother Standard® has created the “gold standard” in cancer care.
- Patient Empowerment MedicineSM, where patients and caregivers are positioned at the center of their care, voicing opinions and participating in their own treatment decisions.
- CTCA offers exclusive technologies and treatment protocols: TomoTherapy® radiation treatment to pinpoint and more safely treat cancer, and Fractionated Dose Chemotherapy to minimize the side effects of conventional chemotherapy (see “Tech” sheet).

